SCIENTIFIC BACKGROUND

ACVRL1, BMPR1B, BMPR2, CAV1, EIF2AK4, ENG, GDF2, KCNA5, KCNK3, SMAD1, SMAD4, SMAD9, TBX4

Category:

Scientific Background

Pulmonary arterial hypertension (PAH) is a group of various forms of pulmonary hypertension. PAH can occur sporadically with no known cause (idiopathic pulmonary arterial hypertension, IPAH) or with a family history (hereditable pulmonary arterial hypertension, HPAH). Furthermore, PAH may be associated with other diseases, such as connective tissue diseases, HIV infection or liver disease, or may be induced by certain drugs. PAH is characterized by a mean pulmonary arterial pressure (PAP) of >25mmHg at rest (determined by right heart catheterization) at normal pulmonary capillary occlusion pressure (wedge pressure) ≥15mmHg and by increased vascular resistance (PVR). Typical changes in the pulmonary vessels increasingly lead to vasoconstriction and thus to overworking of the right heart, which can ultimately lead to right heart failure.

 

Hereditable pulmonary arterial hypertension (HPAH) is an autosomal dominant inherited disease with incomplete penetrance. Heterozygous changes in the BMPR2 gene (bone morphogenetic receptor 2, a member of the transforming growth factor beta (TGF-ß) family) have been identified in about 75% of patients with HPAH and in about 15-20% of patients with IPAH. These include de novo variants and hereditary cases, whose family background often remains undiscovered due to incomplete penetrance among other things. The penetrance is significantly higher for women (42%) than for men (approximately 14%). The time of onset of the disease can vary greatly, from early childhood to late adulthood. In rarer cases (approximately 1-3%) causative variants may also be present in other genes (e.g., ACVRL1, BMPR1B, CAV1, EIF2AK4, ENG, GDF2, KCNA5, KCNK3, SMAD1, SMAD4, SMAD9 and TBX4).

 

Since patients with PAH usually show only non-specific symptoms such as fatigue, exhaustion and exercise dyspnea, it may be 2-3 years after the onset of the first symptoms before a diagnosis is made. The initial symptoms also include syncope, chest pain, palpitations and edema in the feet. An early diagnosis is very important for successful therapy, because starting therapy early significantly improves the prognosis and the quality of life. Molecular genetic diagnostics supplements common diagnostic methods.

 

References

Gamou et al. 2018, Clin Genet 94:70 / Ma et Chung 2017, J Pathol 241:273 / Song et al. 2016, Clin Sci (Lond) 130:2043 / Chung et al. 2015, Can J Cardiol 31:544 / Ma et Chung 2014, Hum Genet 133:471 / Austin et Loyd 2014, Circ Res 115:189 / Kwapiszewska et al. 2014, Dtsch Med Wochenschr 139: S111 / Kerstjens-Frederikse et al. 2013, Med Genet 50:500 / Pabst et al. 2010, Pharm Unserer Zeit 36:448 / Hoeper et al. 2010, Pneumologie, 64:401 / Girerd et al. 2010, Am J Respir Crit Med 181:851 / Machado et al. 2009, J Am Coll Cardiol 54:S32 / Simmonneau et al. 2009, J Am Coll Cardiol 54:S43 / Montani et al. 2009, Eur Respir Rev 18:272 / Müller et al. 2006, Med Genet 4:318

GENES

ACVRL1, BMPR1B, BMPR2, CAV1, EIF2AK4, ENG, GDF2, KCNA5, KCNK3, SMAD1, SMAD4, SMAD9, TBX4

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more